Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Stock Price Today
Aura AI Summary
Key Stats
- $2.03BMarket Cap
- 12,241,664Volume
- Fixed IncomeSector
- $44.1452W High
- $25.1952W Low
- 28 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Direxion Daily 20 Year Treasury Bull 3X Shares has traded between a low of $25.19 and a high of $44.14, highlighting its annual price range. Buy and sell Direxion Daily 20 Year Treasury Bull 3X Shares shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Most Recent News
ZenaTech launches AI-powered smart safety glasses Stacklens for field technicians, with pilots in 2027.
ZenaTech introduced Stacklens™, AI-powered smart safety glasses designed for field technicians and industrial workers, integrating hands-free AI assistance, real-time video support, and thermal imaging. The glasses aim to improve efficiency by allowi...
Class action lawsuit filed over Compass-Anywhere merger alleging regulatory misrepresentation.
The Rosen Law Firm has filed a class action lawsuit on behalf of former Anywhere Real Estate shareholders who received Compass, Inc. stock in a January 2026 merger. The suit alleges that Compass and its executives misrepresented their efforts to secu...
New data supports Furoscix ReadyFlow autoinjector for outpatient edema management in heart failure and CKD.
MannKind presented new clinical data at HFSA 2026 showing that Furoscix ReadyFlow, an autoinjector delivering subcutaneous furosemide, provides diuretic effects comparable to IV administration for treating edema in heart failure and chronic kidney di...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.